Variant · Snv
EGFR E114K
CI-VAR-00000657Explore in graph →NP_005219.2:p.Glu114LysNM_005228.5:c.340G>AClinVar 1059673 CIViC 3464 rs1219568637
Curated evidence
Evidence by cancer (4 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 31290142
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Neoplasm2 | ||||||||
| EGFR E114K | (oncogenic) | Oncogenic | D | Supports Oncogenicity | 3 | submitted | EID9586The oncogenic potential of somatic EGFR mutations found in colorectal cancer samples were tested. IL-3 independent growth of Ba/F3 cells was achieved when cells were transduced with EGFR E114K. NIH-3T… (full text at CIViC) PMID 31290142 · Kim et al., 2020 · Open in CIViC | civic |
| EGFR E114K | Cetuximab + PanitumumabSubstitutes | Predictive | D | Supports Sensitivity Response | 4 | submitted | EID9587Oncogenic somatic EGFR mutations found in colorectal cancer samples were tested for sensitivity to EGFR inhibitors cetuximab and panitumumab. Ba/F3 cells expressing EGFR E114K showed a dose-dependent … (full text at CIViC) PMID 31290142 · Kim et al., 2020 · Open in CIViC | |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1059673 | Uncertain significance | criteria provided, multiple submitters, no conflicts | 2 | EGFR-related lung cancer; Lung cancer; Inflammatory skin and bowel disease, neonatal, 2; Hereditary cancer-predisposing syndrome | germline | 3 | Nov 01, 2025 | clinvar |